Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
1.850
0.00 (0.00%)
Sep 6, 2024, 4:00 PM EDT - Market closed
Biodesix Market Cap
Biodesix has a market cap or net worth of $268.58 million as of September 6, 2024. Its market cap has increased by 102.09% in one year.
Market Cap
268.58M
Enterprise Value
288.96M
1-Year Change
102.09%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since the IPO on October 28, 2020, Biodesix's market cap has decreased from $472.57M to $268.58M, a decrease of -43.17%. That is a compound annual growth rate of -13.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2024 | 268.60M | 61.32% |
| Dec 29, 2023 | 166.50M | 72.00% |
| Dec 30, 2022 | 96.80M | -32.26% |
| Dec 31, 2021 | 142.90M | -73.29% |
| Dec 31, 2020 | 535.10M | 13.23% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prelude Therapeutics | 280.62M |
| Cartesian Therapeutics | 280.54M |
| Poseida Therapeutics | 277.76M |
| Inogen | 277.04M |
| uniQure | 271.25M |
| Design Therapeutics | 267.82M |
| Enanta Pharmaceuticals | 267.40M |
| Biomea Fusion | 263.97M |